Renal Medullary Carcinoma - 4 Studies Found
Recruiting |
: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma :
|
Recruiting |
: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer :
: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Completed |
: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer :
: 2007-04-20 : Drug: Sunitinib Malate 50 mg by mouth daily for 4 weeks, then 2 weeks off. |